Prediction and reasons for COVID-19 second dose vaccine hesitation

a cross-sectional study in a municipality of Brazil

Autores

Palavras-chave:

COVID-19, Vaccination hesitancy, Vaccination, Vaccination refusal, Anti-vaccination movement

Resumo

BACKGROUND: Hesitation and refusal to take a second dose of the vaccine for coronavirus disease 19 (COVID-19) are prevalent. OBJECTIVES: We aimed to identify predictive factors for hesitation or refusal and describe groups with higher rates of vaccine hesitancy. DESIGN AND SETTING: A cross-sectional study in Assis City, Brazil. METHODS: The study included adults who passed the due date for taking the COVID-19 second dose vaccine. Participants were recruited in December 2021 using a mobile-based text message. Sociodemographic and clinical data and reasons for hesitance were collected. The outcome was the attitude towards completing the recommended second dose of the vaccine. Bivariate and multivariate Poisson analyses were performed to determine the adjusted predictors. RESULTS: Participants between 30–44 years of age had a 2.41 times higher prevalence of hesitation than those aged 18–29 years. In addition, people who had adverse events or previously had COVID-19 had 4.7 and 5.4 times higher prevalences of hesitation, respectively (P value < 0.05). CONCLUSION: We found a significant group of adults aged between 30–44 years who refused the second dose of the COVID-19 vaccine. Furthermore, those who reported adverse effects after the first dose and those who had COVID-19 previously were a significant group for refusal.

Downloads

Não há dados estatísticos.

Biografia do Autor

Carlos Izaias Sartorão Filho, Fundação Educacional do Município de Assis

MD, PhD. Professor of Medicine, Fundação Educacional do Município de Assis (FEMA), Assis (SP), Brazil.

Mariana Costa Zoqui, Fundação Educacional do Município de Assis

Medicine Student, Fundação Educacional do Município de Assis (FEMA), Assis (SP), Brazil.

Douglas Otomo Duarte, Fundação Educacional do Município de Assis

Medicine Student, Fundação Educacional do Município de Assis (FEMA), Assis (SP), Brazil.

Edy Alyson Ribeiro, Fundação Educacional do Município de Assis

Medicine Student, Fundação Educacional do Município de Assis (FEMA), Assis (SP), Brazil.

Vinicius César Queiroz Bisetto, Fundação Educacional do Município de Assis

Medicine Student, Fundação Educacional do Município de Assis (FEMA), Assis (SP), Brazil.

Lara Escobar Gavião Cachoni, Fundação Educacional do Município de Assis

Medicine Student, Fundação Educacional do Município de Assis (FEMA), Assis (SP), Brazil.

Ana Luísa Varrone Sartorão, Fundação Educacional do Município de Assis

Medicine Student, Fundação Educacional do Município de Assis (FEMA), Assis (SP), Brazil.

Diogo Coutinho Terribile, Fundação Educacional do Município de Assis

Medicine Student, Fundação Educacional do Município de Assis (FEMA), Assis (SP), Brazil.

Beatriz Balsimelli de Mello, Fundação Educacional do Município de Assis

Medicine Student, Fundação Educacional do Município de Assis (FEMA), Assis (SP), Brazil.

Carlos Izaias Sartorão Neto, Fundação Educacional do Município de Assis

Medicine Student, Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo (SP), Brazil.

Roberto de Mello, Fundação Educacional do Município de Assis

MD. Deputy Provider, Santa Casa da Misericordia de Assis Assis (SP), Brazil.

Referências

Lazarus JV, Ratzan SC, Palayew A, et al. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2021;27(2):225-8. PMID: 33082575; https://doi.org/10.1038/s41591-020-1124-9.

MacDonald NE; SAGE Working Group on Vaccine Hesitancy. Vaccine hesitancy: Definition, scope and determinants. Vaccine. 2015;33(34):4161-4. PMID: 25896383; https://doi.org/10.1016/j.vaccine.2015.04.036.

Larson HJ, Jarrett C, Eckersberger E, Smith DM, Paterson P. Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007-2012. Vaccine. 2014;32(19):2150-9. PMID: 24598724; https://doi.org/10.1016/j.vaccine.2014.01.081.

Lane S, MacDonald NE, Marti M, Dumolard L. Vaccine hesitancy around the globe: Analysis of three years of WHO/UNICEF Joint Reporting Form data-2015-2017. Vaccine. 2018;36(26):3861-7. PMID: 29605516; https://doi.org/10.1016/j.vaccine.2018.03.063.

Hotez PJ. COVID19 meets the antivaccine movement. Microbes Infect. 2020;22(4-5):162-4. PMID: 32442682; https://doi.org/10.1016/j.micinf.2020.05.010.

Kriss JL, Reynolds LE, Wang A, et al. COVID-19 Vaccine Second-Dose Completion and Interval Between First and Second Doses Among Vaccinated Persons - United States, December 14, 2020-February 14, 2021. MMWR Morb Mortal Wkly Rep. 2021;70(11):389-95. PMID: 33735162; https://doi.org/10.15585/mmwr.mm7011e2.

Dooling K, McClung N, Chamberland M, et al. The Advisory Committee on Immunization Practices’ Interim Recommendation for Allocating Initial Supplies of COVID-19 Vaccine - United States, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(49):1857-9. PMID: 33301429; https://doi.org/10.15585/mmwr.mm6949e1.

Lazarus JV, Ratzan S, Palayew A, et al. COVID-SCORE: A global survey to assess public perceptions of government responses to COVID-19 (COVID-SCORE-10). Hotchkiss D, editor. PLoS One. 2020;15(10):e0240011. PMID: 33022023; https://doi.org/10.1371/journal.pone.0240011.

Sallam M. COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates. Vaccines (Basel). 2021;9(2):160. PMID: 33669441; https://doi.org/10.3390/vaccines9020160.

Roozenbeek J, Schneider CR, Dryhurst S, et al. Susceptibility to misinformation about COVID-19 around the world. R Soc Open Sci. 2020;7(10):201199. PMID: 33204475; https://doi.org/10.1098/rsos.201199.

Robinson E, Jones A, Lesser I, Daly M. International estimates of intended uptake and refusal of COVID-19 vaccines: A rapid systematic review and meta-analysis of large nationally representative samples. Vaccine. 2021;39(15):2024-34. PMID: 33722411; https://doi.org/10.1016/j.vaccine.2021.02.005.

Lamptey E, Serwaa D, Appiah AB. A nationwide survey of the potential acceptance and determinants of COVID-19 vaccines in Ghana. Clin Exp Vaccine Res. 2021;10(2):183-90. PMID: 34222131; https://doi.org/10.7774/cevr.2021.10.2.183.

Moore DCBC, Nehab MF, Camacho KG, et al. Low COVID-19 vaccine hesitancy in Brazil. Vaccine. 2021;39(42):6262-8. PMID: 34535318; https://doi.org/10.1016/j.vaccine.2021.09.013.

Sprengholz P, Eitze S, Korn L, Siegers R, Betsch C. The power of choice: Experimental evidence that freedom to choose a vaccine against COVID-19 improves willingness to be vaccinated. Eur J Intern Med. 2021;87:106-8. PMID: 33810941; https://doi.org/10.1016/j.ejim.2021.03.015.

Dula J, Mulhanga A, Nhanombe A, et al. COVID-19 Vaccine Acceptability and Its Determinants in Mozambique: An Online Survey. Vaccines (Basel). 2021;9(8):828. PMID: 34451953; https://doi.org/10.3390/vaccines9080828.

Sartorao Filho CI, Sartotao Neto CI, Sartorao ALV, et al. Using Mobile Phone-based Text Message to Recruit Representative Samples: Assessment of a Cross-Sectional Survey about the COVID-19 Vaccine Hesitation. medRxiv. 2022.01.15.22269259. https://doi.org/10.1101/2022.01.15.22269259.

Downloads

Publicado

2023-05-04

Como Citar

1.
Filho CIS, Zoqui MC, Duarte DO, Ribeiro EA, Bisetto VCQ, Cachoni LEG, Sartorão ALV, Terribile DC, Mello BB de, Neto CIS, Mello R de. Prediction and reasons for COVID-19 second dose vaccine hesitation: a cross-sectional study in a municipality of Brazil. Sao Paulo Med J [Internet]. 4º de maio de 2023 [citado 14º de março de 2025];141(3):1-7. Disponível em: https://periodicosapm.emnuvens.com.br/spmj/article/view/469

Edição

v. 141 n. 3 (2023)

Seção

Artigo Original

Licença

Creative Commons License
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.